Courtney Johnson

Title: Innovator Spotlight: Courtney Johnson and Her Groundbreaking Patent

Introduction: Courtney Johnson, an accomplished inventor based in West Lafayette, IN, has made significant strides in the field of pharmaceutical development. With a focus on creating innovative compounds, she is paving the way for advancements in the treatment of various diseases and disorders.

Latest Patents: Johnson holds a patent for "Salt forms and solvates of Mcl-1 antagonists." This patent discloses various salt and solvate forms of a specific chemical compound, namely (1S,3'R,6′R,7′S,8′E,11′S,12′R)-6-chloro-7′-methoxy-11′,12′-dimethyl-3,4-dihydro-2H,15′H-spiro[naphthalene-1,22′-[20]oxa[13]thia[1,14]diazatetracyclo[14.7.2.00]pentacosa[8,16,18,24]tetraen]-15′-one 13′,13′-dioxide (AMG 176). The patent outlines crystalline salt and solvate forms of this compound, along with methods for their synthesis and use in treating various medical conditions.

Career Highlights: Courtney Johnson is employed at Amgen Inc., a renowned biotechnology company recognized for its innovative research and development in medicine. Her role involves extensive experimentation and formulation of therapeutic compounds, contributing to the company’s mission of alleviating patient suffering.

Collaborations: Throughout her career, Johnson has worked closely with her colleague, Henry Morrison. Their collaborative efforts have led to the development of new methodologies and further advancements in the pharmaceutical field, promoting a culture of innovation within their team.

Conclusion: Courtney Johnson exemplifies the essence of innovation in the pharmaceutical industry. Her patented work represents a vital contribution to the development of Mcl-1 antagonists, showcasing her ability to combine scientific expertise with a passion for improving health outcomes. As she continues her work at Amgen Inc., Johnson remains a key player in medicinal research, driving forward the frontiers of healthcare innovation.